Breakthrough discoveries require vision as well as courage
The molecule is the same either way
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Then, the cells were switched to seahorse XF DMEM base medium and incubated in the absence of CO 2 at 37 C for 1 h
When shes not leading international wellness retreats, she is chasing sunsets, handstanding in nature, or geeking out over mitochondria
Looking toward the future The wheels of progress on multi-agonists, oral small molecules, and tissue-targeted approaches are moving forward at breakneck speed